Luradisone for the treatment of major depressive disorder

• Research type

  Research Study

• Full title

  A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder with Mixed Features (Protocol No D1050304)

• IRAS ID

  124340

• Sponsor organisation

  Sunovion Pharmaceuticals Inc.

• Eudract number

  2012-004132-33

• Clinicaltrials.gov Identifier

  NCT01421134

• REC name

  North West - Greater Manchester South Research Ethics Committee

• REC reference

  13/NW/0117

• Date of REC Opinion

  2 May 2013

• REC opinion

  Further Information Favourable Opinion